CAPZA announces a record fundraising of more than €1 billion for the Artemid Senior Loan IV fund (“ASL IV”) and its co-investment vehicles. This amount includes approximately €700 million commitments for ASL IV, €190 million through co-investments, and €120 million for an evergreen fund dedicated to an institutional investor.

The latest generation raised a total amount 75% above its predecessor, underscoring growing investor interest in this strategy. The fundraising brought together around twenty French and European investors, one-third of which constitute new clients.

With the renewed confidence of its historical investors (insurers, mutual insurance groups, French institutional investors and family offices) and the arrival of new subscribers (pension funds, foreign insurers, etc.), the success of this third vintage demonstrates the relevance of the investment strategy and the robustness of the team’s track-record².

The Artemid Senior Loans strategy specialises in bullet senior debt financings with maturities of five to eight years for predominantly unlisted European companies with EBITDA between €8 million and €100 million and moderate leverage. These financings support acquisitions and corporate growth initiatives. The Artemid Senior Loan range now manages €1.6 billion in assets and forms an integral part of the private debt and alternative credit platform of Europe’s leading asset manager, created through the combination of AXA Investment Managers’ alternative investment activities and BNP Paribas Group.

With over 60% of capital already deployed, ASL IV and its co-investment vehicles have financed over 25 companies, with individual investments ranging from €10 million to €50 million. More than 90% of these transactions incorporate non-financial criteria, notably ESG aspects, to encourage borrowers to accelerate their progress on sustainability.

This success is reinforced by a strategic expansion of the team, now comprising seven experienced professionals, including a Director based in Munich, underscoring our ambition to expand the Artemid Senior Loans strategy across Europe. ASL IV has already completed its first investments in Germany and Italy and continues to grow its footprint in the Netherlands and Spain, working closely with CAPZA’s other teams in Paris, Milan, Munich, Madrid, and Amsterdam.

Building on this achievement, CAPZA plans to launch a new vintage in 2026, which, in line with the previous generation, will offer bullet senior financings with five- to eight-year maturities under similar criteria.

The various Artemid fundraisings, totalling more than €2 billion, have already financed over 90 mid-cap companies.

“We welcome this encouraging trend, which is gaining further traction. The renewed trust of existing investors and onboarding of new clients, including several international players, confirm the strength and relevance of the strategy. This success reinforces our positioning in low-leverage senior financings for midcaps and demonstrates the value of offering flexible, tailored solutions,” – Annie-Laure Servel, Managing Partner, Artemid SAS.

Christophe Fritsch, Global Head of Alternative Credit at AXA IM Alts, commented:“The successful fundraising for our Artemid Senior Loans strategy, exceeding our initial target and attracting 30% new investors, reflects market recognition of our team’s expertise built over more than 10 years. This achievement confirms AXA IM Alts’ ability to provide clients with a comprehensive range of alternative credit solutions and privileged access to diverse opportunities, while supporting portfolio diversification in private debt—a rapidly growing asset class.”

Information about the staff teams Artemid SAS is only informative. We do not guarantee the fact that staff remain employed by CAPZA (Atalante) and exercise or continue to exercise in the Artemid SAS teams.

For professional investors only. Before making any investment decision, please refer to the fund’s constitutive documentation.

Due to its simplified nature, this communication may be incomplete, and the opinions, estimates, and scenarios presented herein may be subjective and are subject to change without prior notice. No assurance can be given as to the actual realization of the scenarios described. All data, figures, statements, analyses, forecasts, and any other information contained in this document are provided based on our knowledge at the date of its creation. It remains solely at the reader’s discretion to rely on the information described herein.